BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3169091)

  • 1. An evaluation of the SCM test for the diagnosis of cancer of the breast.
    Chaitchik S; Deutsch M; Asher O; Krauss G; Lebovich P; Michlin H; Weinreb A
    Eur J Cancer Clin Oncol; 1988 May; 24(5):861-6. PubMed ID: 3169091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour specificity of the SCM test for cancer diagnosis.
    Chaitchik S; Asher O; Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence polarisation changes in lymphocyte cytoplasm as a diagnostic test for breast carcinoma.
    Ron IG; Deutsch M; Tirosh R; Weinreb A; Eisenthal A; Chaitchik S
    Eur J Cancer; 1995 Jun; 31A(6):917-20. PubMed ID: 7646921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of the cellscan technique for the SCM test in breast cancer.
    Rahmani H; Deutsch M; Ron I; Gerbat S; Tirosh R; Weinreb A; Chaitchik S; Lalchuk S
    Eur J Cancer; 1996 Sep; 32A(10):1758-65. PubMed ID: 8983287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
    Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
    Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT.
    Klein O; Lin S; Embon O; Sazbon A; Zidan J; Kook AI
    J Urol; 1999 Jun; 161(6):1994-6. PubMed ID: 10332488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the SCM test in cancer diagnosis.
    Atkinson RJ; Lowry WS; Strain P
    Cancer; 1983 Jul; 52(1):91-100. PubMed ID: 6342753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence polarization changes in the lymphocytic cytoplasm in the various stages of breast cancer.
    Ron I; Deutsch M; Merimsky O; Tirosh R; Rachmani H; Kaufman M; Weinreb A; Chaitchik S
    Oncol Rep; 1996 Jan; 3(1):197-9. PubMed ID: 21594343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of malignant process in benign lesions of breast tumor by measurements of changes in structuredness of cytoplasmic matrix in circulating lymphocytes (SCM test) reinduced in vitro by specific tumor antigen.
    Klein O; Linn S; Davidson C; Hadary A; Shukha A; Zidan J; Eitan A; Kook AI
    Breast; 2002 Dec; 11(6):478-83. PubMed ID: 14965713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach for high sensitivity detection of breast cancer by analysis of changes in structure of the cytoplasmic matrix of lymphocytes specifically induced by a specific breast tumour antigen (MUC-l/SEC).
    Klein O; Linn S; Hadari A; Davidson C; Eitan A; Zidan J; Kook AI
    Breast; 2002 Apr; 11(2):137-43. PubMed ID: 14965660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
    Hashimoto Y; Takaku F; Yamanaka T
    Br J Cancer; 1979 Jul; 40(1):156-60. PubMed ID: 454560
    [No Abstract]   [Full Text] [Related]  

  • 14. New SCM (structuredness of the cytoplasmatic matrix)-based approach in breast cancer detection.
    Birindelli S; Colnaghi MI; Pilotti S
    Tumori; 1996; 82(6):550-3. PubMed ID: 9061062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
    Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
    Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.
    Cercek L; Cercek B; Franklin CI
    Br J Cancer; 1974 May; 29(5):345-52. PubMed ID: 4136566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.
    Cercek L; Cercek B
    Br J Cancer; 1976 May; 33(5):539-43. PubMed ID: 1276032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal lavage findings in women with known breast cancer undergoing mastectomy.
    Khan SA; Wiley EL; Rodriguez N; Baird C; Ramakrishnan R; Nayar R; Bryk M; Bethke KB; Staradub VL; Wolfman J; Rademaker A; Ljung BM; Morrow M
    J Natl Cancer Inst; 2004 Oct; 96(20):1510-7. PubMed ID: 15494601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polarization-sensitive multimodal imaging for detecting breast cancer.
    Patel R; Khan A; Quinlan R; Yaroslavsky AN
    Cancer Res; 2014 Sep; 74(17):4685-93. PubMed ID: 24958468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancer.
    Schnuda ND
    Cancer; 1980 Sep; 46(5):1164-73. PubMed ID: 7214300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.